A Novel MCL1 Inhibitor Combined with Venetoclax Rescues Venetoclax-Resistant Acute Myelogenous Leukemia-Reference-Cited by-同舟云学术

A Novel MCL1 Inhibitor Combined with Venetoclax Rescues Venetoclax-Resistant Acute Myelogenous Leukemia

Published:2018-09-05 Issue:12 Volume:8 Page:1566-1581
ISSN:2159-8274
Container-title:Cancer Discovery
language:en
Short-container-title:Cancer Discov

Author:

Ramsey Haley E.,Fischer Melissa A.^ORCID,Lee Taekyu,Gorska Agnieszka E.,Arrate Maria Pia,Fuller Londa,Boyd Kelli L.,Strickland Stephen A.,Sensintaffar John,Hogdal Leah J.,Ayers Gregory D.,Olejniczak Edward T.,Fesik Stephen W.,Savona Michael R.^ORCID

Funder

Biff Ruttenberg Foundation

Edward P. Evans Foundation

HHS | National Institutes of Health (NIH)

Adventure Allie Discovery Research Grant

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology

Cited by 265 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery and development of thiazolidine-2,4-dione derivatives as Bcl-2/Mcl-1 dual inhibitors;Bioorganic Chemistry;2024-10

2. The Clinicopathological and Molecular Characteristics of Endocervical Gastric-Type Adenocarcinoma and the Use of Claudin18.2 as a Potential Therapeutic Target;Modern Pathology;2024-10

3. Relapse and resistance in acute myeloid leukemia post venetoclax: improving second lines therapy and combinations;Expert Review of Hematology;2024-09-13

4. Sorafenib and SIAIS361034, a novel PROTAC degrader of BCL-xL, display synergistic antitumor effects on hepatocellular carcinoma with minimal hepatotoxicity;Biochemical Pharmacology;2024-09

5. CRISPR screen of venetoclax response-associated genes identifies transcription factor ZNF740 as a key functional regulator;Cell Death & Disease;2024-08-27